Clinical Trials on Intraoperative Hypotension in Portugal

Total 75 results

University Institute of Maia
University of Southern Denmark

Completed

Recreational Futsal for Controlled Hypertension (HyperFut)

Hypertension | Blood Pressure | Blood Pressure Disorders | Hypertension,Essential

Portugal
Centro Hospitalar De São João, E.P.E.

Completed

The Impact of Carvedilol Posology on Clinically Significant Portal Hypertension

Clinically Significant Portal Hypertension

Portugal
Bayer

Completed

Non-interventional Multi-center Study on Patients Under Routine Treatment of Pulmonary Arterial Hypertension (PAH) With Inhaled Iloprost Using I-Neb as a Device for Inhalation (COMPHI)

Pulmonary Hypertension

Portugal
Aveiro University
University Institute of Maia; Cardiology Department, Hospital Infante D. Pedro... and other collaborators

Completed

The Role of Exercise Training in the Treatment of Resistant Hypertension (EnRIcH)

Resistant Hypertension

Portugal
Centro Hospitalar de Lisboa Central
NOVA Medical School

Unknown

Continuous Passive Paracentesis for Intra-abdominal Hypertension (COPPTRIAHL)

Critical Illness | Cirrhosis, Liver | Ascites Hepatic | Paracentesis | Hypertension, Intraabdominal

Portugal
Alcon Research

Terminated

Study of Travatan and Cosopt in Primary Open-Angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Open-angle Glaucoma

Portugal
Juvantia Pharma Ltd
Santhera Pharmaceuticals

Unknown

Fipamezole in Neurogenic Orthostatic Hypotension (Foehn)

Parkinson's Disease | Multiple System Atrophy | Symptomatic Neurogenic Orthostatic Hypotension (NOH)

France, Portugal
Centro Hospitalar de Lisboa Central

Completed

Screening of Diastolic Dysfunction With Impedance Cardiography in Hypertensive Patients (IMPEDDANS)

Hypertension | Diastolic Dysfunction

Portugal
Universidade do Porto
Fundação para a Ciência e a Tecnologia; Centro Hospitalar De São João, E.P.E.; Instituto Nacional de Saúde Doutor Ricardo Jorge

Unknown

Study With an Innovative Equipment to Monitor and Control SALT During Cooking (iMC_SALT)

Hypertension | Salt; Excess

Portugal
Academia Cuf Descobertas
NOVA Medical School; CUF Academic and Research Medical Center; José de Mello... and other collaborators

Completed

Effect of a Multi-component Education Program on Salt Reduction in Adults

Hypertension | Blood Pressure

Portugal
University of Trás-os-Montes and Alto Douro

Completed

Study of the Long-term Effects of Exercise on Heath Indicators in Older People

Lipid Metabolism Disorders | Sarcopenia | Osteoporosis | Overweight and Obesity | Personal Satisfaction | Hypertension With Complications and Secondary Hypertension

Portugal
Centro Hospitalar do Baixo Vouga

Unknown

Posterior Cornea in Primary Open Angle Glaucoma

Glaucoma

Portugal
Universidade Nova de Lisboa
Hospital da Luz, Portugal; Centro Hospitalar Lisboa Ocidental; Centro Hospitalar... and other collaborators

Active, not recruiting

Kynurenine/Tryptophan Ratio in Hypertension Associated to Obstructive Sleep Apnea (KYNTOSA)

Hypertension Secondary

Portugal
Allergan

Completed

Safety and Efficacy of Bimatoprost/Timolol Fixed Combination Versus Latanoprost in Patients With Open-Angle Glaucoma Who Have Never Been Treated

Glaucoma, Open-Angle

Spain, Portugal
Centro Hospitalar Universitário Lisboa Norte
Unidade Local de Saúde do Alto Minho; ACES Lisboa Norte; Equipa Regional dos... and other collaborators

Enrolling by invitation

Glaucoma Portugal Screening Trial (Glaucoma PoST)

Glaucoma

Portugal
University Institute of Maia
University of Connecticut; Aveiro University; Hospital Infante D. Pedro, Centro... and other collaborators

Completed

The Hypotensive Effects of Home-Based Isometric Handgrip Training in Older Adults With Pre-Hypertension and Hypertension - The HoldAge Trial

Hypertension | Pre-Hypertension

United States, Portugal
Bial - Portela C S.A.

Completed

Safety and Efficacy of BIA 5-1058 in PAH

Pulmonary Arterial Hypertension

Austria, Germany, Italy, Portugal, Spain, United Kingdom
Association for Innovation and Biomedical Research...
European Vision Institute Clinical Research Network

Completed

Intraocular Pressure and Tolerability Study of Preservative-free Prostaglandins (Bimatoprost and Latanoprost) on Glaucoma and Ocular Hypertension: European, Multicentric, Investigator-led, Single Masked Study (SPORT)

Ocular Hypertension | Glaucoma

United Kingdom, Switzerland, Belgium, Italy, Portugal, Austria
Universidade Nova de Lisboa

Completed

Evaluation of Antihypertensive Drugs in OSA Patients (ADOSA)

Hypertension | Obstructive Sleep Apnea

Portugal
Centro Hospitalar de Lisboa Central
NOVA Medical School

Enrolling by invitation

LMWH for Treatment of Early Fetal Growth Restriction (HepaGrowth) (HepaGrowth)

Pre-Eclampsia | Fetal Growth Retardation | Prematurity

Portugal
Sankyo Pharma Gmbh

Completed

Olmesartan in Essential Hypertension

Essential Hypertension

Austria, Germany, Italy, Netherlands, Portugal, Spain, Switzerland, United Kingdom
EyeTechCare

Completed

Glaucoma Treatment Using Focused Ultrasound in Open Angle Glaucoma Patients

Glaucoma

Belgium, Israel, Italy, Portugal
Associação para o Desenvolvimento do Centro Académico...
European Regional Development Fund; Loulé Municipal Council; Albufeira Municipal... and other collaborators

Recruiting

Algarve Active Ageing - Cardiac and Osteoarthritis Rehabilitation (A3-COR) (A3-COR)

Hypertension | Osteoarthritis, Knee | Dyslipidemias | Type 2 Diabetes | Myocardial Infarction, Acute | Smoking Habit

Portugal
AOP Orphan Pharmaceuticals AG
GCP-Service International Ltd. & Co. KG; ANOVA CRO s.r.o.; PharmaLex Belgium; Aixial...

Recruiting

Initial Triple Therapy Including Parenteral Treprostinil vs Initial Double Oral Therapy in PAH Group I Patients (TripleTRE)

Pulmonary Arterial Hypertension

Austria, Spain, France, Germany, Italy, Czechia, Hungary, Poland, Portugal, Romania
Abbott Medical Devices

Completed

Observational Study of the EnligHTN Renal Denervation System in Europe

Uncontrolled Hypertension

Spain, Belgium, Estonia, Italy, Portugal, United Kingdom
Theravance Biopharma

Terminated

Phase 3 Open-Label Extension Study of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure (OAK)

Symptomatic Neurogenic Orthostatic Hypotension

United States, Spain, Portugal, United Kingdom, France, Denmark, Ukraine, Israel, Estonia, Poland, Italy, Russian Federation, Australia, Austria, Bulgaria, Canada, Germany, New Zealand
Bayer

Completed

EXPERT, EXPosurE Registry RiociguaT in Patients With Pulmonary Hypertension (EXPERT)

Hypertension, Pulmonary

Turkey, Austria, Czechia, Russian Federation, Slovakia, Switzerland, Italy, Germany, United Kingdom, France, Belgium, Canada, Colombia, Greece, Luxembourg, Netherlands, Spain, Taiwan, Denmark, Sweden, Argentina, Portugal, Saudi Arabia, Austral... and more
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

A Phase 1, Open-Label Study of Latanoprost Acid Plasma Concentrations in Pediatric and Adult Glaucoma Patients Treated With Latanoprost.

Ocular Hypertension | Glaucoma

United States, Spain, Italy, Denmark, Portugal, South Africa
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

A Study Comparing The Efficacy, Safety And Tolerability Of Latanoprost 75, 100 And 125 ug/ml To Xalatan In The Treatment Of Primary Open-Angle Glaucoma And Ocular Hypertension

Primary Open Angle Glaucoma | Ocular Hypertension

United Kingdom, France, Australia, Thailand, Portugal, Pakistan, Czechia, Greece
Bayer

Completed

Safety Follow-up Study of Inhaled Iloprost in Patients With Pulmonary Hypertension

Hypertension, Pulmonary

Belgium, France, Spain, Netherlands, Italy, Portugal, Poland
Bayer

Completed

Observation of Patients With Primary Pulmonary Hypertension Receiving Prescribed Ventavis Inhalation Therapy Regarding Safety and Efficacy for up to 4 Years

Hypertension, Pulmonary

Italy, Spain, France, Germany, Portugal, United Kingdom
Italian Institute of Telemedicine
BPLab

Completed

International Registry for Ambulatory Blood Pressure and Arterial Stiffness Telemonitoring (VASOTENS)

Hypertension

Russian Federation, Argentina, Armenia, Australia, Italy, Kazakhstan, Mexico, Portugal, Romania, Ukraine
Theravance Biopharma

Completed

Clinical Effect of Ampreloxetine (TD-9855) for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure (SEQUOIA)

Symptomatic Neurogenic Orthostatic Hypotension

United States, Spain, Israel, Hungary, Portugal, Australia, Canada, Germany, Russian Federation, Estonia, France, Italy, United Kingdom, Denmark, Poland, New Zealand, Austria, Bulgaria, Ukraine
Actelion

Completed

Effect of Selexipag on Daily Life Physical Activity of Patients With Pulmonary Arterial Hypertension. (TRACE)

Pulmonary Arterial Hypertension

United States, United Kingdom, Ireland, Germany, Austria, France, Norway, Portugal, Sweden, Switzerland
Clinical Hospital Centre Zagreb
European Society of Hypertension

Unknown

Blood Pressure Control in ESH Excellence Centres (BP-CON)

White Coat Hypertension | Blood Pressure | Lifestyle Risk Reduction

Israel, Greece, Belgium, Germany, Armenia, Austria, Bulgaria, Croatia, Czechia, Estonia, Italy, Lebanon, Lithuania, Netherlands, Poland, Portugal, Romania, Serbia, Spain, Sweden, Ukraine, United Kingdom
Theravance Biopharma

Recruiting

Phase 3 Efficacy and Durability of Ampreloxetine for the Treatment of Symptomatic nOH in Participants With Multiple System Atrophy (CYPRESS)

MSA - Multiple System Atrophy | Symptomatic Neurogenic Orthostatic Hypotension

United States, Spain, United Kingdom, Hungary, Italy, Argentina, Austria, Poland, Germany, Portugal, Belgium, Brazil, Denmark, Canada, France, Chile, Estonia
United Therapeutics

Completed

Efficacy and Safety of Oral UT-15C Tablets to Treat Pulmonary Arterial Hypertension (FREEDOM-C2)

Pulmonary Hypertension

United States, Canada, Germany, Spain, Belgium, Sweden, Israel, France, Italy, Netherlands, Portugal, United Kingdom
Ionis Pharmaceuticals, Inc.

Recruiting

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ION464 Administered to Adults With Multiple System Atrophy (HORIZON) (HORIZON)

Multiple System Atrophy

Austria, Portugal, France, Germany, United Kingdom
Sanofi

Completed

AVE7688 in Patients With Mild to Moderate Blood Pressure (RAVEL-1)

Hypertension

United States, Canada, Brazil, Poland, Russian Federation, Germany, Italy, Netherlands, Portugal, Spain, Turkey, Malaysia, Singapore, Taiwan, Mexico, Argentina, Korea, Republic of, Chile, Hong Kong, South Africa, Greece
Theravance Biopharma

Terminated

Phase 3 Clinical Effect Durability of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure (REDWOOD)

Parkinson's Disease (PD) | MSA | Symptomatic Neurogenic Orthostatic Hypotension | Pure Autonomic Failure (PAF)

United States, Spain, United Kingdom, Canada, France, Estonia, Australia, Israel, Denmark, Italy, Poland, New Zealand, Germany, Ukraine, Austria, Bulgaria, Portugal, Hungary, Russian Federation
Bayer

Completed

Riociguat rEplacing PDE-5i Therapy evaLuated Against Continued PDE-5i thErapy (REPLACE)

Pulmonary Arterial Hypertension

Belgium, France, Spain, Portugal, Turkey, United States, Germany, Korea, Republic of, Mexico, Austria, Canada, Denmark, Poland, Italy, Greece, Taiwan, Czechia, Netherlands, Japan, Brazil, United Kingdom
Actelion

Completed

Effects of the Combination of Bosentan and Sildenafil Versus Sildenafil Monotherapy on Pulmonary Arterial Hypertension (PAH) (Compass-2)

Pulmonary Arterial Hypertension

United States, Denmark, Sweden, Germany, Spain, Brazil, Saudi Arabia, Portugal, Greece, Slovakia, United Kingdom, Czech Republic
Sankyo Pharma Gmbh

Completed

Olmesartan and an add-on Treatment in Patients With Mild to Moderate Hypertension (OLMETREAT)

Essential Hypertension

France, Austria, Switzerland, Belgium, Germany, Italy, Netherlands, United Kingdom, Portugal
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Long-Term Non-Interventional Latanoprost Study (LYNX)

Ocular Hypertension | Glaucoma

Spain, Czechia, Sweden, Germany, France, Greece, Belgium, Colombia, Denmark, Italy, Peru, Portugal, Slovakia, United Kingdom
Boehringer Ingelheim

Active, not recruiting

A Study to Test Whether Two Different Doses of Avenciguat Help People With Liver Cirrhosis and High Blood Pressure in the Portal Vein (Main Vessel Going to the Live

Hypertension, Portal

Spain, Denmark, United Kingdom, Singapore, Germany, Italy, Austria, Canada, Croatia, China, Taiwan, Netherlands, Belgium, United States, Korea, Republic of, Japan, Argentina, France, Switzerland, Portugal, Israel, Romania
Aerovate Therapeutics

Recruiting

Inhaled Imatinib Pulmonary Arterial Hypertension Clinical Trial - Follow Up Long Term Extension (IMPAHCT-FUL) (IMPAHCT-FUL)

Pulmonary Arterial Hypertension

United States, Belgium, Italy, Spain, Australia, Canada, China, Singapore, France, United Kingdom, Latvia, Mexico, Argentina, Israel, South Africa, Chile, Poland, Germany, Portugal, Colombia
Bayer

Completed

BAY63-2521 - Long-term Extension Study in Patients With Chronic Thromboembolic Pulmonary Hypertension (CHEST-2)

Pulmonary Hypertension

Belgium, France, Spain, Turkey, Portugal, Taiwan, Japan, United States, Switzerland, Korea, Republic of, Austria, Canada, China, Denmark, Germany, Mexico, Russian Federation, Argentina, Italy, Poland, Australia, Brazil, Czechia, United... and more
GB002, Inc.

Recruiting

Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA)

Pulmonary Arterial Hypertension

United States, Spain, Israel, Korea, Republic of, Netherlands, France, Singapore, United Kingdom, Lithuania, Australia, Latvia, Argentina, Portugal, Greece, Czechia, Puerto Rico, Belgium, Italy, Poland, Romania, Serbia, Austria, Chile, Denma... and more
Bayer

Completed

A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With CTEPH. (CHEST-1)

Pulmonary Hypertension

Belgium, France, Spain, Turkey, Portugal, Taiwan, Japan, United States, Switzerland, Korea, Republic of, Austria, Canada, China, Denmark, Germany, Russian Federation, Mexico, Argentina, Netherlands, Italy, Poland, United Kingdom, Au... and more
Actelion

Terminated

Clinical Study to Assess the Long-term Safety, Tolerability, and Efficacy of Macitentan in Subjects With Eisenmenger Syndrome (MAESTRO-OL)

Pulmonary Arterial Hypertension

China, Malaysia, United States, Austria, Bulgaria, Chile, France, Germany, Greece, Mexico, Philippines, Poland, Portugal, Romania, Russian Federation, Serbia, Spain, United Kingdom, Vietnam

Clinical Trials on Intraoperative Hypotension in Portugal

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Trinidad & Tobago

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations